These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 9065649)

  • 1. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
    Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
    Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.
    Cortesina G; Martone T; Galeazzi E; Olivero M; De Stefani A; Bussi M; Valente G; Comoglio PM; Di Renzo MF
    Int J Cancer; 2000 May; 89(3):286-92. PubMed ID: 10861506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression.
    Beviglia L; Matsumoto K; Lin CS; Ziober BL; Kramer RH
    Int J Cancer; 1997 Jun; 74(3):301-9. PubMed ID: 9221809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells.
    Singh-Kaw P; Zarnegar R; Siegfried JM
    Am J Physiol; 1995 Jun; 268(6 Pt 1):L1012-20. PubMed ID: 7611423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-met proto-oncogene expression in benign and malignant human prostate tissues.
    Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW
    J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression.
    Natali PG; Nicotra MR; Di Renzo MF; Prat M; Bigotti A; Cavaliere R; Comoglio PM
    Br J Cancer; 1993 Oct; 68(4):746-50. PubMed ID: 8104462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-met overexpression in supraglottic laryngeal squamous cell carcinoma and its relation to lymph node metastases.
    Yücel OT; Sungur A; Kaya S
    Otolaryngol Head Neck Surg; 2004 Jun; 130(6):698-703. PubMed ID: 15195055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the met/HGF receptor in renal cell carcinomas.
    Natali PG; Prat M; Nicotra MR; Bigotti A; Olivero M; Comoglio PM; Di Renzo MF
    Int J Cancer; 1996 Jun; 69(3):212-7. PubMed ID: 8682590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas.
    Di Renzo MF; Olivero M; Ferro S; Prat M; Bongarzone I; Pilotti S; Belfiore A; Costantino A; Vigneri R; Pierotti MA
    Oncogene; 1992 Dec; 7(12):2549-53. PubMed ID: 1334253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of scatter factor and c-met receptor in benign and malignant breast tissue.
    Jin L; Fuchs A; Schnitt SJ; Yao Y; Joseph A; Lamszus K; Park M; Goldberg ID; Rosen EM
    Cancer; 1997 Feb; 79(4):749-60. PubMed ID: 9024713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
    Humphrey PA; Zhu X; Zarnegar R; Swanson PE; Ratliff TL; Vollmer RT; Day ML
    Am J Pathol; 1995 Aug; 147(2):386-96. PubMed ID: 7639332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.
    Knowles LM; Stabile LP; Egloff AM; Rothstein ME; Thomas SM; Gubish CT; Lerner EC; Seethala RR; Suzuki S; Quesnelle KM; Morgan S; Ferris RL; Grandis JR; Siegfried JM
    Clin Cancer Res; 2009 Jun; 15(11):3740-50. PubMed ID: 19470725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erbB proto-oncogene expression.
    O-Charoenrat P; Rhys-Evans P; Eccles S
    Anticancer Res; 2001; 21(3B):1953-63. PubMed ID: 11497283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
    Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
    Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas.
    Di Renzo MF; Olivero M; Martone T; Maffe A; Maggiora P; Stefani AD; Valente G; Giordano S; Cortesina G; Comoglio PM
    Oncogene; 2000 Mar; 19(12):1547-55. PubMed ID: 10734314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer.
    Nagy J; Curry GW; Hillan KJ; McKay IC; Mallon E; Purushotham AD; George WD
    Surg Oncol; 1996 Feb; 5(1):15-21. PubMed ID: 8837300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MET receptor is overexpressed but not mutated in oral squamous cell carcinomas.
    Morello S; Olivero M; Aimetti M; Bernardi M; Berrone S; Di Renzo MF; Giordano S
    J Cell Physiol; 2001 Dec; 189(3):285-90. PubMed ID: 11748586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the HGF/Met signaling in head and neck squamous cell carcinoma: Focus on tumor immunity (Review).
    Liu D; Zhong M; Zhan D; Zhang Y; Liu S
    Oncol Rep; 2020 Dec; 44(6):2337-2344. PubMed ID: 33125120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.